Eris Lifesciences Limited (ERIS.NS)
INR 1401.3
(0.86%)
INR 1401.3
(0.86%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.54 Billion INR | -4.23% |
| 2022 | 6.83 Billion INR | 750.09% |
| 2021 | 803.94 Million INR | 1707.83% |
| 2020 | 44.47 Million INR | -27.62% |
| 2019 | 61.44 Million INR | 1996.93% |
| 2018 | 2.93 Million INR | -99.89% |
| 2017 | 2.74 Billion INR | 55405.06% |
| 2016 | 4.94 Million INR | 0.0% |
| 2015 | - INR | -100.0% |
| 2014 | 5 Million INR | 0.0% |
| 2013 | - INR | -100.0% |
| 2012 | 5.63 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 19.66 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 6.54 Billion INR | -4.23% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 6.54 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 6.32 Billion INR | 0.0% |
| 2022 Q4 | 6.83 Billion INR | 0.0% |
| 2022 Q2 | 1.22 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 6.83 Billion INR | 750.09% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 803.94 Million INR | 1707.83% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 803.94 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 399.73 Million INR | 0.0% |
| 2020 FY | 44.47 Million INR | -27.62% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 44.47 Million INR | 0.0% |
| 2020 Q2 | 51.13 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 61.44 Million INR | 1996.93% |
| 2019 Q4 | 61.44 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 83.11 Million INR | 0.0% |
| 2018 Q2 | 1.74 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 2.93 Million INR | 0.0% |
| 2018 FY | 2.93 Million INR | -99.89% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q2 | 4.24 Million INR | 0.0% |
| 2017 Q4 | 2.74 Billion INR | 0.0% |
| 2017 FY | 2.74 Billion INR | 55405.06% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 FY | 4.94 Million INR | 0.0% |
| 2016 Q4 | 4.94 Million INR | 0.0% |
| 2016 Q2 | - INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2015 FY | - INR | -100.0% |
| 2014 FY | 5 Million INR | 0.0% |
| 2013 FY | - INR | -100.0% |
| 2012 FY | 5.63 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 265.79 Million INR | -2362.423% |
| Ind-Swift Limited | 10.09 Billion INR | 35.165% |
| Bajaj HealthCare Limited | 650.34 Million INR | -906.4% |
| Sakar Healthcare Limited | 549.55 Million INR | -1090.987% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 69.342% |
| Innova Captab Limited | 2.1 Billion INR | -210.9% |
| Divi's Laboratories Limited | 20 Million INR | -32625.35% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -23412.969% |
| Morepen Laboratories Limited | 33.64 Million INR | -19356.213% |
| Mankind Pharma Limited | 325.81 Million INR | -1908.83% |
| Sequent Scientific Limited | 1.42 Billion INR | -358.598% |
| Wanbury Limited | 820 Million INR | -698.179% |
| Laurus Labs Limited | 7.98 Billion INR | 18.005% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -366.476% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -4334.029% |
| Alembic Limited | 73.9 Million INR | -8756.658% |
| Hikal Limited | 4.22 Billion INR | -54.785% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -940.883% |
| Neuland Laboratories Limited | 449.2 Million INR | -1357.031% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -2668.642% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -331.474% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Themis Medicare Limited | 267.74 Million INR | -2344.562% |
| RPG Life Sciences Limited | -30.3 Million INR | 21700.891% |
| Zydus Lifesciences Limited | 251 Million INR | -2507.598% |
| Lupin Limited | 1.55 Billion INR | -321.501% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -46757.603% |
| Wockhardt Limited | 8.91 Billion INR | 26.542% |
| Vaishali Pharma Limited | 35.98 Million INR | -18089.339% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -1636167.5% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -8560.937% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 79.334% |
| FDC Limited | 2.46 Million INR | -265312.409% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | -9.267% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Venus Remedies Limited | 386.8 Million INR | -1592.107% |
| ZIM Laboratories Limited | 356 Million INR | -1738.472% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -1738.906% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -71042.065% |
| Shilpa Medicare Limited | 5.6 Billion INR | -16.843% |
| Albert David Limited | 6.01 Million INR | -108694.382% |
| Ajanta Pharma Limited | 235.2 Million INR | -2682.768% |
| Hester Biosciences Limited | 1.81 Billion INR | -260.068% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -2982.122% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | -457.312% |
| Gufic Biosciences Limited | 1.53 Billion INR | -325.106% |
| Windlas Biotech Limited | 20.18 Million INR | -32333.449% |
| Procter & Gamble Health Limited | 68.8 Million INR | -9413.183% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -20198.714% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -4801.169% |
| Granules India Limited | 689.71 Million INR | -848.96% |
| Aarti Drugs Limited | 2.75 Billion INR | -137.717% |
| Bal Pharma Limited | 363.82 Million INR | -1698.966% |
| Alkem Laboratories Limited | 400 Million INR | -1536.268% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -49111.053% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Medicamen Biotech Limited | 12.55 Million INR | -52031.183% |
| Unichem Laboratories Limited | 382.22 Million INR | -1612.378% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -5986.625% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Valiant Laboratories Limited | 750.89 Million INR | -771.631% |
| Orchid Pharma Limited | 1.2 Billion INR | -443.476% |
| Medico Remedies Limited | 8.67 Million INR | -75373.593% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -5763.392% |
| Ipca Laboratories Limited | 5.8 Billion INR | -12.766% |
| Brooks Laboratories Limited | 3.56 Million INR | -183492.426% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 537021.247% |
| Piramal Enterprises Limited | 535.85 Billion INR | 98.779% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 59.195% |
| NATCO Pharma Limited | 53 Million INR | -12249.189% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -256.68% |
| Strides Pharma Science Limited | 6.71 Billion INR | 2.53% |
| Indoco Remedies Limited | 3.51 Billion INR | -86.082% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -6039.841% |